
Ibc Pharmaceuticals Private Limited
Pharmaceutical company specializing in manufacturing, research, packaging, and marketing of pharmaceutical and nutraceutical products.
Pharmaceutical company specializing in manufacturing, research, packaging, and marketing of pharmaceutical and nutraceutical products.
Ibc Pharmaceuticals Private Limited (IPPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 April 2011 and has a history of 14 years. Its registered office is in Thane, Maharashtra.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.10 M and a paid-up capital of Rs 0.44 M.
The company currently has active open charges totaling ₹2.00 Cr.
Rajeev Kabbur, Deepak Kabbur, Ravindranath Talasila, and Two other members serve as directors at the Company.
+91-XXXXXXXXXX
U24239MH2011PTC215791
215791
Private Limited Indian Non-Government Company
05 Apr 2011
30 Sep 2024
31 Mar 2024
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Deepak Kabbur ![]() | Director | 29-Nov-2017 | Current |
Rajeev Kabbur ![]() | Director | 14-Feb-2020 | Current |
Ravindranath Talasila ![]() | Director | 29-Nov-2017 | Current |
Kranthikiran Siddappa ![]() | Director | 29-Nov-2017 | Current |
Shubham Mishra ![]() | Director | 05-Apr-2011 | Current |
Ibc Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 247.57% increase. The company also saw a substantial improvement in profitability, with a 168.88% increase in profit. The company's net worth Soared by an impressive increase of 37.17%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Ibc Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Deepak Kabbur and Shubham Mishra are mutual person
Deepak Kabbur and Shubham Mishra are mutual person
Shubham Mishra is a mutual person
Shubham Mishra is a mutual person
Shubham Mishra is a mutual person
Deepak Kabbur and Ravindranath Talasila are mutual person
₹20.00 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
14 Nov 2024 | State Bank Of India | ₹2.00 Cr | Open |
Unlock and access historical data on people associated with Ibc Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ibc Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ibc Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with State Bank Of India amounted to Rs. 20.00 M with Charge ID 101026770 was registered on 14 Nov 2024.
Ibc Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ibc Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Rajeev Virbhadra Kabbur was appointed as a Director was appointed as a Director on 14 Feb 2020 & has been associated with this company since 5 years 2 months .
Deepak Virbhadra Kabbur was appointed as a Director was appointed as a Director on 29 Nov 2017 & has been associated with this company since 7 years 4 months .
Ravindranath Tagore Talasila was appointed as a Director was appointed as a Director on 29 Nov 2017 & has been associated with this company since 7 years 4 months .
Ibc Pharmaceuticals Private Limited was incorporated on 05 Apr 2011.
The authorized share capital of Ibc Pharmaceuticals Private Limited is ₹ 1.10 M and paid-up capital is ₹ 0.44 M.
Currently 5 directors are associated with Ibc Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Ibc Pharmaceuticals Private Limited is Office No 705 And 706 Arihant Aura Plot No.13/1 Ttc Industrial Area, Turbhe India, Thane, Maharashtra, 400705.
The corporate identification number (CIN) of Ibc Pharmaceuticals Private Limited is U24239MH2011PTC215791 and the company number is 215791 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Ibc Pharmaceuticals Private Limited has risen by 247.57%.
The financial reports for the fiscal year 2023 indicates that The net worth of Ibc Pharmaceuticals Private Limited has experienced an upsurge of 37.17%.
As per the financial statements for fiscal Year 2023, The total open charges for Ibc Pharmaceuticals Private Limited amount to ₹ 2.00 Cr.
The most recent Balance Sheet for Ibc Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
VM
KK